Welcome to Sam Global Biocare Pvt. Ltd.
Empowering Global Healthcare through Quality Pharmaceuticals
Trusted by Partners in Iraq, Sudan and Libya
International Business Overview
Who We Are
Fast Growing Pharma Company
Sam Global BioCare is a trusted Indian pharmaceutical exporter, delivering high-quality medicines to international markets. We specialize in generics and specialty drugs across oncology, cardiology, neurology, and infectious diseases.
With a commitment to quality, reliability, and innovation, we strive to make healthcare accessible and affordable for communities worldwide.
Our products are designed to meet global standards, ensuring safety and efficacy in every dose.
The Beginning:
Founded in January 2022, Sam Global BioCare aims to provide quality pharmaceuticals to underserved markets, starting with special import permissions in Iraq to establish strong regional growth.
Market Entry & Regulatory Milestones:
Achieved over $3M in shipments to Baghdad with special import approvals, initiated key regulatory filings, registered 56 dossiers in Kurdistan, and built strong market presence and credibility in Iraq.
Strategic Growth:
In 2024, we expanded into Iraq, Libya, and Sudan, dossier submissions, strengthened regulatory partnerships, and currently have 23 Dossiers under registration in Baghdad.
Focused on trust, compliance & global healthcare access.
- Founded in 2022 to serve emerging markets with quality pharma products.
- Team of 80+ across business, regulatory, and operations.
- 56+ products registered in Kurdistan.
- Expanding into Malaysia, Lebanon, Sudan, Libya.
- Source from EU/WHO-GMP certified plants in India, Jordan & Europe.
- Act as MAH in multiple countries.
- Hold exclusive registrations for Vital Healthcare (SVP) in Iraq.
What We Do
Enabling Healthcare Access with Regulatory Excellence.
- We take full regulatory responsibility in all active markets
- We provide CTD/ACTD dossiers tailored to country-specific requirements for smooth registrations
- From submissions to renewals, we support every step of the registration process.
- We manage all interactions with health authorities to ensure timely approvals and compliance.
- We ensure secure export from certified EU-GMP, TGA, WHO-GMP, and UK MHRA manufacturing facilities.
- Our products are registered across Middle East.
- We deliver end-to-end business development, regulatory, and operational support.
Global Presence
Since our inception, Sam Global BioCare has rapidly expanded into multiple international markets through strategic partnerships, trusted manufacturers, and strong regulatory expertise.
Registered / Operating Markets (We are actively present in):
- Iraq
- Sudan
- Libya
Upcoming Markets:
- Uzbekistan
- Australia
Our Partners
Your Gateway to Global Pharma:
- Partner with Us to Register and Launch Quality Medicines in Your Market
- Regulatory-ready dossiers and products from EU-GMP, TGA Australia, and UK MHRA-approved facilities.
- Complete support for global registration, licensing, and distribution.
Why Partner with Us
At Sam Global BioCare, we bring more than products — we bring reliability, compliance, and commitment. Here’s what sets us apart:
- Partner with us to bring world-class medicines to your market — efficiently, compliantly, and reliably
- We act as the MAH in multiple countries, ensuring full regulatory ownership and faster market access.
- We provide eCTD/CTD-format dossiers, adapted per country regulations — saving time and reducing approval cycles.
- We partner with WHO-GMP, EU-GMP, TGA, and UK MHRA-approved manufacturers in India, Jordan, and Europe.
- Dossiers can be prepared in 30 days, and samples are available on request for partner evaluations.
- Over 56 products registered in Kurdistan, active expansion in Malaysia, Libya, and Sudan — with upcoming filings in UK and Australia.
- Our regulatory, BD, and documentation teams work hand-in-hand with your local consultants to ensure smooth submissions.
Expanded Offerings – On Demand
At Sam Global BioCare, we don’t just offer what’s ready — we deliver what’s required.
In addition to our ready-to-file dossiers, we have access to a wider range of over 400+ oral dosage products, supported by trusted WHO-GMP and EU-GMP-certified manufacturing partners. These dossiers can be customized and compiled on demand based on your market’s specific requirements.
Our On-Demand Capabilities Include
400+ Oral Dosage Products:
Tablets, capsules, and suspensions across therapeutic segments like gastro, antidiabetics, antihypertensives, and more.
Full Dossier Preparation:
CTD/ACTD format dossiers prepared within 30 working days, tailored to country-specific regulations.
BE/BA Study Support:
For selected products, we can coordinate bioequivalence or bioavailability data for higher regulatory markets.
Regulatory Flexibility:
Artwork, PILs, and dossiers can be customized with your partner’s name and packaging language.
Our Purpose
At Sam Global BioCare, our purpose is to build long-term, honest, and transparent partnerships in the global pharmaceutical industry — starting from India and reaching markets like Iraq, Sudan, and Libya.
We are not just exporters. We are your direct, single point of contact in India — no middlemen, no confusion. When you partner with us, you get clear communication, personal attention, and full support from our experienced team.
We understand the unique needs of each country and focus on relationship-building instead of one-time transactions. Our aim is to make every partner feel confident, respected, and supported — whether it’s through dossier registration, product sourcing, or regulatory coordination.
We welcome our partners to visit our office, discuss openly, and see how we work. We believe trust grows when people meet, talk, and plan together.
With strong foundations in Iraq, ongoing expansion into Sudan and Libya, and connections to certified Indian manufacturers, we are here to deliver not just medicines — but peace of mind.
